• Neuronetics Inc STIM.OQ STIM.O is expected to show a fall in quarterly revenue when it reports results on March 4 for the period ending December 31 2024

• The Malvern Pennsylvania-based company is expected to report a 3.3% decrease in revenue to $19.634 million from $20.31 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $20.00 million.

• ​LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 25 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Neuronetics Inc is $3.00​, below​ its last closing price of $4.28. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated February 28 at 14:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)